Immune to Cancer: The CRI Blog
-
Translating Science into Survival at the 8th Annual CICON Conference
CRI is proud to co-host the eighth annual Cancer Immunotherapy Conference (CICON) alongside the European Network for… -
Immune Cell Triads Unveil a Critical Role in Fighting Solid Tumors
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
Can a simple blood test tell you how your cancer therapy works?
According to a recent study published in Nature Medicine, blood from patients can be used to screen… -
Peggy Zuckerman is a Resilient Kidney Cancer Survivor and Here’s Why She is a Passionate Advocate for Awareness
In 2004, North Dakota resident and educator Peggy Zuckerman was told by her doctor that she had… -
Meet Gordon Levine: CRI ImmunoAdvocate, Stage 4 Colorectal Cancer Survivor, and Immunotherapy Champion
CRI ImmunoAdvocate Gordon Levine’s fight against colorectal cancer was not linear. The lawyer-by-trade first sought treatment in… -
How CRI’s Immunotherapy Breakthroughs and Research are Shaping Cancer Treatment and Prevention
Today, cancer immunotherapy is the most forward-thinking and innovative form of cancer treatment for patients. Cancer immunotherapy… -
Celebrating the Impact of CRI-Funded Black Immunologists in Cancer Immunotherapy
The impacts of Black people on cancer research and immunotherapy have been instrumental, going back to at… -
The CRI 2024 Spanish-Language Immunotherapy Summit is Available Online
CRI is proud to continue its commitment to the U.S. Hispanic and Spanish-speaking cancer community with on-demand…